Skip to main content

Year: 2023

Splicing Tapes Market Size Worth USD 701.0 Million in 2032 | Emergen Research

Rising demand for splicing tapes in the packaging sector is one of the major factors driving Splicing Tapes market revenue growth. Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) — The global splicing tapes market size was USD 583.6 Million in 2022 and is expected to register a steady revenue CAGR of 1.9% during the forecast period, according to latest analysis by Emergen Research. Rising demand for splicing tapes in the packaging sector for joining rolls of materials such as paper, plastic, and film is the key factor driving market revenue growth.  Splicing tapes are used to combine two materials to increase their strength or provide continuity of a substrate. Splicing procedure help operators to avoid long downtimes and conduct continuous production without having to re-thread the material through their equipment. Request Free Sample...

Continue reading

Vanguard Investments Canada Announces Final 2023 Annual Capital Gains Distributions for the Vanguard ETFs®

TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Vanguard Investments Canada Inc. today announced the final annual capital gains distributions for the Vanguard ETFs listed below for the 2023 tax year. This is an update to the estimated annual capital gains distributions announced on November 15, 2023 and December 20, 2023.   These amounts are for the year-end capital gains distributions only, which will be re-invested and the resulting units immediately consolidated, so that the number of units held by each investor will not change. The annual capital gains distributions do not include the ongoing monthly or quarterly cash distribution amounts, which are reported in a separate press release. The ex-dividend date for the 2023 annual distributions for these ETFs will be December 28, 2023. The record date will be December 29, 2023 and payable...

Continue reading

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

MARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”), together with any accrued dividends, were automatically converted into shares of the Company’s Common Stock on December 22, 2023, in accordance with the Preferred Stock terms set forth in the Company’s Articles of Incorporation. As a result of this conversion, approximately 30 million shares of Common Stock have been added to the Company’s share count. The conversion of the shares ends the dividend accrual associated with the Preferred Stock. Commenting on the conversion, MIMEDX Chief Executive Officer, Joseph H. Capper stated, “Today marks an important milestone in our journey to improve MIMEDX’s financial...

Continue reading

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

Fully funded 7.9 EH/s, increasing self-mining capacity by 58% Building 3 at the Lake Mariner facility now fully operational Planning for additional growth with construction of Building 4 already underway Expansion of existing HPC project supporting generative AI planned for 2024 EASTON, Md., Dec. 28, 2023 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), which owns and operates vertically integrated, domestic Bitcoin mining facilities powered by more than 91% zero-carbon energy, today provided a business update. Key HighlightsFully funded 7.9 EH/s expansion, increasing self-mining capacity by 58%.Building 3 at the Lake Mariner facility is operational and ready for delivery, installation and energization of new miners.Estimated deployment date of February 1, 2024, for all 18,500 BITMAIN Antminer...

Continue reading

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the pricing of a public offering of 2,692,308 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined offering price of $1.30 per share (or pre-funded warrant in lieu thereof) and associated warrant. The warrants will have an exercise price of $1.30 per share and will be immediately exercisable upon issuance for a period of five years following the date of issuance. The closing of the offering is expected to occur on or about January 2, 2024, subject to the satisfaction...

Continue reading

AGF Investments Announces Final Distributions for AGF Investments ETFs for 2023

TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments ) today announced the final December 2023 cash distributions and annual 2023 reinvested capital gains distributions for the AGF Investments ETFs listed on the Toronto Stock Exchange or NEO Exchange. Unitholders of record of an AGF Investments ETF on December 29, 2023 will receive (i) the actual 2023 reinvested capital gains distributions payable in respect of that AGF investments ETF on December 29, 2023; and (ii) the actual December 2023 cash distributions payable in respect of that AGF Investments ETF on January 5, 2024. The actual taxable amounts for 2023, including the tax characteristics, will be reported in early 2024. The annual reinvested capital gains distributions generally represent realized capital gains within the AGF Investments ETFs and...

Continue reading

Bullet Blockchain Announces Preliminary Fourth Quarter Revenue Results and Comments on 2024 Outlook

Bullet Blockchain’s subsidiary, First Bitcoin Capital LLC, continues to pursue unlicensed violators of Bullet Blockchain’s Intellectual Property RENO, NV, Dec. 28, 2023 (GLOBE NEWSWIRE) — via NewMediaWire - Bullet Blockchain, Inc. (“BULT” or the “Company”) (OTC: BULT), a pioneering software development and SaaS company at the forefront of blockchain and Bitcoin ATM technologies, proudly announces a significant milestone: preliminary 2023 fourth quarter gross revenue will likely exceed $740,000. “We delivered a solid fourth quarter which is reflective of our acquisition strategy and improved Bitcoin pricing. While the upcoming Bitcoin halving and anticipated trading of a Bitcoin ETF is lifting the market in the short term, we are seeing the cryptocurrency environment continue to improve and anticipated demand for our products and...

Continue reading

Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA™ Software for OGM Data Analysis in Constitutional Genetic Disease Research

SAN DIEGO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced significant upgrades to its pipeline for analysis of optical genome mapping (OGM) data in its VIA™ software for applications in constitutional genetic disease. The latest analysis pipeline, Bionano Solve 3.8.1, enhances the sensitivity and specificity for structural variation (SV) detection from OGM data, which, when combined with copy number variant (CNV) analysis capabilities introduced in July 2023, further advance OGM’s leadership in variant detection. Together with the enhanced performance for SV and CNV calling, VIA software now enables the most comprehensive visualization, interpretation and reporting of SVs and CNVs from OGM data in constitutional genetic disease research. Features of the VIA software that apply to...

Continue reading

Carbide Inserts Market Size Worth USD 2.06 Billion in 2032 | Emergen Research

Rising demand for carbide inserts in industrial manufacturing is a key driving factor driving carbide inserts market revenue growth Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) — The global carbide inserts market size was USD 1.26 Billion in 2022 and is expected to register a rapid revenue CAGR of 5% during the forecast period. In the rapidly evolving landscape of industrial manufacturing, the global carbide inserts market is experiencing substantial growth, driven by the rising demand for carbide tools across various industries. Notably, aerospace, automobile, material handling, and construction sectors are leveraging carbide inserts to achieve high-precision metal shaping and grounding, leading to increased efficiency and profitability. One of the key factors contributing to the market’s revenue growth is the swift integration...

Continue reading

Natural Fragrance Market Size Worth USD 8.8 Million in 2032 | Emergen Research

Rising consumer demand regarding natural products is one of the major factors driving Natural Fragrance market revenue growth Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) — The global natural fragrance market size was USD 3.8 Million in 2022 and is expected to register a steady revenue CAGR of 8.8% during the forecast period, according to latest analysis by Emergen Research. Increasing social media promotions and advertisements is a key factor driving market revenue growth. Natural fragrance is derived from natural materials, such as plants and fruits, which has various applications, including perfumes, cosmetics, and food. These fragrances have healthy demand from consumers due to increasing awareness about the use of natural fragrances over synthetic fragrances and low toxicity of these compounds. For instance, on 18 August 2023,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.